BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumours
Clinical trial NCT02273388 · COMPLETED
Trial details
- NCT number
- NCT02273388
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-04
- Primary completion
- 2009-01-19
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.